Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
48.20
+0.22 (0.46%)
Jun 2, 2026, 2:14 PM EDT - Market open
Boston Scientific Revenue
Boston Scientific had revenue of $5.20B in the quarter ending March 31, 2026, with 11.58% growth. This brings the company's revenue in the last twelve months to $20.62B, up 17.44% year-over-year. In the year 2025, Boston Scientific had annual revenue of $20.07B with 19.87% growth.
Revenue (ttm)
$20.62B
Revenue Growth
+17.44%
P/S Ratio
3.46
Revenue / Employee
$349,390
Employees
59,000
Market Cap
71.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.07B | 3.33B | 19.87% |
| Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
| Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
| Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
| Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
| Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
| Dec 31, 2019 | 10.74B | 912.00M | 9.28% |
| Dec 31, 2018 | 9.82B | 775.00M | 8.57% |
| Dec 31, 2017 | 9.05B | 662.00M | 7.89% |
| Dec 31, 2016 | 8.39B | 909.00M | 12.16% |
| Dec 31, 2015 | 7.48B | 97.00M | 1.31% |
| Dec 31, 2014 | 7.38B | 237.00M | 3.32% |
| Dec 31, 2013 | 7.14B | -106.00M | -1.46% |
| Dec 31, 2012 | 7.25B | -373.00M | -4.89% |
| Dec 31, 2011 | 7.62B | -184.00M | -2.36% |
| Dec 31, 2010 | 7.81B | -382.00M | -4.67% |
| Dec 31, 2009 | 8.19B | 138.00M | 1.71% |
| Dec 31, 2008 | 8.05B | -307.00M | -3.67% |
| Dec 31, 2007 | 8.36B | 536.00M | 6.85% |
| Dec 31, 2006 | 7.82B | 1.54B | 24.48% |
| Dec 31, 2005 | 6.28B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories | 45.13B |
| Medtronic | 35.48B |
| Stryker | 25.27B |
| GE HealthCare Technologies | 20.98B |
| Koninklijke Philips | 20.34B |
| Zimmer Biomet Holdings | 8.41B |
| Edwards Lifesciences | 6.30B |
| Smith & Nephew | 6.16B |
BSX News
- 2 hours ago - Boston Scientific put volume heavy and directionally bearish - TheFly
- 1 day ago - Boston Scientific price target lowered to $70 from $71 at Canaccord - TheFly
- 1 day ago - Belo Sun Announces Corporate Update - GlobeNewsWire
- 4 days ago - Boston Scientific price target lowered to $61 from $80 at TD Cowen - TheFly
- 4 days ago - Boston Scientific downgraded to Peer Perform from Outperform at Wolfe Research - TheFly
- 5 days ago - Boston Scientific price target lowered to $71 from $81 at Goldman Sachs - TheFly
- 5 days ago - Boston Scientific price target lowered to $70 from $87 at Citi - TheFly
- 5 days ago - Boston Scientific price target lowered to $70 from $75 at Baird - TheFly